Aurobindo Pharma

Aurobindo Pharma

World Rank (Jul-30-2023)
2545
Market Cap (Jul-30-2023)
5.96 Billion USD
World Rank (Dec-25-2022)
3,990
Market Cap (Dec-25-2022)
3.10 Billion USD
World Rank (Jan-07-2022)
3,011
Market Cap (Jan-07-2022)
5.58 Billion USD
World Rank (Jan-01-2021)
2,138
Market Cap (Jan-01-2021)
7.44 Billion USD
Company Rank in Country in 2023
Rank in India in July-2023 is 123
Company Rank in Country in 2022
Rank in India in 2022 is 134
World Region
Asia
World Subregion
Southern Asia
Billionaires
PV Ramaprasad Reddy
Employee Count
15,690
Employee Count as of Date
As on 2023
Headquarters Country
India
Headquarters City/State
Hyderabad
Annual Revenue in USD
2,992 Million USD
Annual Operating Income in USD
306 Million USD
Annual Net Income in USD
234 Million USD
Annual Results for Period Ending
Mar-2023 ending year
Total Assets in USD
4,849 Million USD
Total Liabilities in USD
1,585 Million USD
Total Equity in USD
3,264 Million USD
Balance Sheet for Period Ending
Mar-2023 ending year
Business Sector LC
Healthcare
Pharmaceutical
HealthCare Products
Company Website
Aurobindo Pharma
Wikipedia
Wikipedia
Yahoo
Yahoo @ BSE
Company Profile

Aurobindo Pharma is Pharmaceutical Company with headquarters in Hyderabad of India.

As on 2020, Aurobindo Pharma has over 23,000 employees and has over 1,600 R&D Team and they have 29 manufacturing facilities, 8 R&D Centres.

Annual Results Summary LC

AUROBINDO PHARMA - Consolidated - Annual Results - Revenue and Net Profit - in Crores INR:

Year EndingTotal IncomeNet ProfitEPS (INR)
Mar-202324,8551,92732.90
Mar-202223,4552,67845.19
Mar-202124,7745,33491.04
Mar-202023,2902,83148.32
Mar-201919,7182,36440.36
Mar-201816,5652,41941.36
Mar-201715,0252,29639.33
Founded Year
1986
ISIN Code
INE406A01037
Stock Category LC
S&P BSE HEALTH CARE
Stock Exchange LC
BSE
NSE